Browsing Tag
Dexcom
4 posts
MiniMed IPO: Medtronic (NYSE: MDT) to separate diabetes business with Nasdaq filing under MMED
Medtronic files IPO for MiniMed, its diabetes business. Find out what the Nasdaq listing means for the company’s strategy, margins, and the diabetes tech sector.
Biolinq’s needle-free glucose monitor wins FDA nod — Could this disrupt Dexcom and Abbott’s CGM dominance?
Biolinq Shine earns FDA de novo clearance as the first needle-free CGM, challenging Dexcom and Abbott in the diabetes tech market.
Dexcom’s 15-day G7 gets FDA nod—Could this be the game-changer for glucose monitoring and stock momentum?
Dexcom’s FDA-approved G7 15 Day CGM delivers record wear time and accuracy—read how it’s transforming diabetes care and investor sentiment.
Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod
Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given…